Patient reported outcomes (PROs) in patients with extensive-stage small cell lung cancer receiving chemotherapy: a pilot project at a treatment tertiary oncology centre
Eaton, Marie A
Lindsay, Colin R
AffiliationNursing, Christie Hospital, Manchester
MetadataShow full item record
AbstractIntroduction: Patients undergoing chemotherapy for small cell lung cancer commonly experience adverse effects from treatment.Many of these symptoms occur outside of routine hospital followup appointments where the opportunity to intervene at an earlier stage may be missed and therefore may result in adverse outcomes. Patient-reported outcomes (PROs) are symptoms or a patient-perceived health status that are reported directly by the patient without interpretation by a clinician or anyone else. Use of electronic reporting of PROs for symptom monitoring improves survival and health-related quality of life compared to usual care. This may be due to early responsiveness to real-time PROs that prevent adverse downstream consequences. Nurses play a vital role in responding to PROs in order to provide symptom management counseling or referral for supportive medications and chemotherapy dose modifications. Methods: This study is a pilot to develop our knowledge and efficacy around the PRO's Tool, with a proposal to assess 20 patients with a small cell lung cancer diagnosis. The pilot aims to recruit all 20 patients to the study by early 2019. Proposed intervention: This pilot project aims to assess the feasibility of a symptom questionnaire comprising of nine (9) key symptoms experienced by lung cancer patients adapted into lay-language from the CTCAE (Common Terminology Criteria for Adverse Events) (Basch, Lancet Oncology 2006) Proposed cohort: Patients with a diagnosis of extensive-stage small cell lung cancer (newly diagnosed or recurrent) who have consented to commence platinum-based chemotherapy Ability to read and understand English Results: The study aims to show that the use of PROs will help to prevent the incidence of adverse events for patients undergoing treatment for extensive stage small cell lung cancer. Conclusion: The findings will be disseminated and a framework further developed for use with other non lung cancer patients.
CitationNeal H, Fenemore J, Eaton M, McEntee D, Wray D, Tay R, et al. Patient reported outcomes (PROs) in patients with extensive-stage small cell lung cancer receiving chemotherapy: a pilot project at a treatment tertiary oncology centre. Lung Cancer. 2019;127:S53-S4.
TypeMeetings and Proceedings